- Home
- MDU vs PTGX Comparison
MDU vs PTGX Comparison
Compare MDU & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDU
- PTGX
- Stock Information
- Founded
- MDU 1924
- PTGX 2006
- Country
- MDU United States
- PTGX United States
- Employees
- MDU N/A
- PTGX N/A
- Industry
- MDU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- MDU Industrials
- PTGX Health Care
- Exchange
- MDU Nasdaq
- PTGX Nasdaq
- Market Cap
- MDU 3.4B
- PTGX 3.3B
- IPO Year
- MDU N/A
- PTGX 2016
- Fundamental
- Price
- MDU $16.81
- PTGX $51.25
- Analyst Decision
- MDU Buy
- PTGX Strong Buy
- Analyst Count
- MDU 2
- PTGX 9
- Target Price
- MDU $17.50
- PTGX $67.11
- AVG Volume (30 Days)
- MDU 1.6M
- PTGX 1.0M
- Earning Date
- MDU 08-07-2025
- PTGX 08-05-2025
- Dividend Yield
- MDU 3.09%
- PTGX N/A
- EPS Growth
- MDU N/A
- PTGX N/A
- EPS
- MDU 1.27
- PTGX 0.86
- Revenue
- MDU $1,844,536,000.00
- PTGX $207,801,000.00
- Revenue This Year
- MDU $11.66
- PTGX N/A
- Revenue Next Year
- MDU $2.45
- PTGX $47.15
- P/E Ratio
- MDU $18.46
- PTGX $59.19
- Revenue Growth
- MDU 91.83
- PTGX N/A
- 52 Week Low
- MDU $13.23
- PTGX $32.50
- 52 Week High
- MDU $20.39
- PTGX $60.60
- Technical
- Relative Strength Index (RSI)
- MDU 53.44
- PTGX 45.80
- Support Level
- MDU $16.37
- PTGX $49.86
- Resistance Level
- MDU $16.93
- PTGX $57.24
- Average True Range (ATR)
- MDU 0.31
- PTGX 2.06
- MACD
- MDU 0.07
- PTGX -0.78
- Stochastic Oscillator
- MDU 87.37
- PTGX 16.14
About MDU MDU Resources Group Inc. (Holding Company)
MDU Resources Group Inc operates in three business segments, which include the electric segment, which generates, transmits, and distributes electricity in Montana, North Dakota, South Dakota, and Wyoming; The natural gas distribution segment distributes natural gas in those states, as well as in Idaho, Minnesota, Oregon, and Washington; The pipeline segment provides natural gas transportation and underground storage services through a regulated pipeline system in the Rocky Mountain and northern Great Plains regions of the United States.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.